Chuan Zhang Selected Research

Oxygen (Dioxygen)

10/2020	Potential effects of SARS-CoV-2 infection during pregnancy on fetuses and newborns are worthy of attention.
1/2020	Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
1/2020	The Case for Measuring Long Bone Hemodynamics With Near-Infrared Spectroscopy.
1/2018	Oxygen and Pt(II) self-generating conjugate for synergistic photo-chemo therapy of hypoxic tumor.
5/2004	Inhibition of inflammation contributes to organ protection of atenolol in sinoaortic-denervated rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chuan Zhang Research Topics

Disease

67	Neoplasms (Cancer) 10/2022 - 07/2015
14	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2016
13	Neoplasm Metastasis (Metastasis) 11/2021 - 07/2007
11	Stroke (Strokes) 01/2022 - 06/2006
10	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 07/2016
10	Inflammation (Inflammations) 01/2022 - 11/2003
8	Carcinogenesis 04/2022 - 01/2016
7	Hypoxia (Hypoxemia) 01/2021 - 11/2017
6	Infections 01/2022 - 02/2005
5	Gastroesophageal Reflux (GERD) 02/2022 - 12/2018
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2006
5	Colitis 12/2021 - 12/2011
4	Non-alcoholic Fatty Liver Disease 10/2022 - 11/2012
4	Heart Failure 09/2022 - 02/2015
4	Phenylketonurias (Phenylketonuria) 01/2022 - 12/2014
4	Wounds and Injuries (Trauma) 01/2022 - 10/2014
4	Melanoma (Melanoma, Malignant) 01/2021 - 01/2021
4	Myocardial Infarction 12/2019 - 01/2006
3	Cardiac Arrhythmias (Arrythmia) 09/2022 - 04/2015
3	Ischemic Stroke 08/2022 - 10/2017
3	Rheumatoid Arthritis 01/2022 - 05/2021
3	Hyperplasia 05/2021 - 01/2012
3	Colonic Neoplasms (Colon Cancer) 05/2021 - 08/2018
3	Hyperthermia 01/2021 - 01/2019
3	Body Weight (Weight, Body) 01/2020 - 01/2017
3	Congenital Abnormalities (Deformity) 01/2020 - 08/2017
3	Hyperglycemia 01/2016 - 01/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 03/2017
2	Hypertrophic Cicatrix (Hypertrophic Scar) 02/2022 - 09/2020
2	Hemiplegia (Spastic Hemiplegia) 01/2022 - 01/2020
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 04/2019
2	Ulcerative Colitis 12/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

27	Pharmaceutical PreparationsIBA 02/2022 - 01/2013
13	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2017
10	Nucleic AcidsIBA 02/2022 - 05/2018
8	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2019
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2002
6	Therapeutic UsesIBA 05/2022 - 08/2017
6	Biological ProductsIBA 05/2022 - 07/2006
6	MicroRNAs (MicroRNA)IBA 04/2022 - 01/2019
6	Small Interfering RNA (siRNA)IBA 01/2022 - 12/2018
6	Botulinum Toxins (Botulinum Toxin)IBA 01/2022 - 01/2017
5	Circular RNAIBA 04/2022 - 01/2021
5	Long Noncoding RNAIBA 01/2022 - 01/2019
5	polyethylene glycol polyethyleneimine nanogelIBA 01/2022 - 01/2020
5	Peptides (Polypeptides)IBA 10/2021 - 11/2017
5	erucylphosphocholineIBA 01/2021 - 01/2016
5	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2018
5	Oxygen (Dioxygen)IBA 10/2020 - 05/2004
4	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022 - 11/2003
4	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2022 - 12/2014
4	AcidsIBA 01/2022 - 01/2018
4	CytokinesIBA 11/2021 - 01/2021
4	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2015
4	3,4-dihydroxyphenyllactic acidIBA 05/2020 - 01/2018
4	Insulin (Novolin)FDA Link 01/2017 - 01/2012
3	EnzymesIBA 01/2022 - 06/2007
3	NucleosidesIBA 01/2022 - 07/2015
3	Pepsin A (Pepsin)IBA 08/2021 - 12/2018
3	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2012
3	A-Form DNA (A-DNA)IBA 01/2021 - 08/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2007
3	Triglycerides (Triacylglycerol)IBA 12/2020 - 11/2012
3	Dextran SulfateIBA 11/2020 - 12/2011
3	ProdrugsIBA 01/2020 - 11/2017
3	Hematoxylin (Haematoxylon)IBA 01/2020 - 02/2005
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2020 - 02/2005
3	NanogelsIBA 06/2019 - 05/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2018 - 10/2017
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2018 - 11/2017
3	OzoneIBA 01/2018 - 04/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 06/2005
3	astragaloside AIBA 07/2006 - 01/2006
2	Fluorescent Dyes (Fluorescent Probes)IBA 10/2022 - 04/2019
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2022 - 04/2017
2	Hyaluronic Acid (Hyaluronan)IBA 02/2022 - 07/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 09/2020
2	glaucocalyxin AIBA 01/2022 - 05/2021
2	PeriostinIBA 01/2022 - 11/2020
2	gamabufotalinIBA 01/2022 - 11/2020
2	TensinsIBA 01/2022 - 01/2019
2	Photosensitizing Agents (Photosensitizers)IBA 01/2022 - 11/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 03/2017
2	Untranslated RNA (Noncoding RNA)IBA 11/2021 - 11/2020
2	PolymersIBA 10/2021 - 01/2021
2	RadiopharmaceuticalsIBA 10/2021 - 01/2021
2	Radioisotopes (Radionuclides)IBA 10/2021 - 01/2021

Therapy/Procedure

32	Therapeutics 09/2022 - 12/2011
15	Drug Therapy (Chemotherapy) 01/2021 - 01/2012
6	Injections 01/2022 - 01/2017
5	Length of Stay 01/2019 - 09/2011
4	Immunotherapy 07/2021 - 08/2018
3	Ligation 01/2019 - 01/2006
3	Osteotomy 10/2018 - 08/2017
3	Catheters 01/2018 - 04/2017
3	Denervation 01/2018 - 11/2003
3	Photochemotherapy (Photodynamic Therapy) 01/2018 - 11/2017
2	Intravenous Injections 05/2022 - 04/2019
2	Radiotherapy 01/2022 - 10/2021